Zhimeng Biopharma’s investigational drug approved to begin phase 2 epilepsy clinical trial in China
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
Now approved for both acute and chronic HCV in adults and children aged 3 and above
A new weapon in the global fight against malaria
FlexiTubes will showcase range of eco-friendly and innovative tube options
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
Subscribe To Our Newsletter & Stay Updated